Namaste Technologies is rolling out a telemedicine portal to connect doctors to medical marijuana patients virtually. The company's co-founder and CEO Sean Dollinger explains how they are bringing this technology to the Canadian market. "NamasteMD is the first application allowed by the app store for telemedicine in Canada ever for cannabis," said Dollinger. He explains his hope for Namaste Technologies to become a global leader in cannabis by leveraging its technology for partners in the market. The company is projecting $30 million in revenue for this year. Namaste Technologies launched in 2014 as a hardware company producing vaporizers. "It allowed us to develop a platform that collected a database and customers around the world," said Dollinger.

Share:
More In Business
AT&T, Verizon Delay 5G Rollout Near Airports, Runways
Telecom giants AT&T and Verizon have agreed to delay activating their 5G services around airports and runways once again. This comes after major U.S. airlines voiced their concern over the rollout of 5G technology, warning of an impending "catastrophic" aviation crisis. Peter Andersen, Chief Investment Officer, Anderson Capital Management joined Cheddar's Opening Bell to discuss.
Earnings Season Kicks Into High Gear
Earnings season kicks into high gear this week as big players are on tap to report their Q4 numbers. Goldman Sachs, Procter & Gamble, United Airlines, and Netflix are just a few of the companies we're keeping a close eye on to give us a better idea of how they're dealing with the Omicron variant, inflation and interest rates. David Nelson, chief strategist at Belpointe, gives a preview of what to expect.
Inflation Among Biggest Concern for CEOs in 2022
Concerns over inflation have become one of the biggest worries for executives. A survey from The Conference Board shows that more than 900 CEOs consider inflation a top tier concern, a major shift from last year's survey that had it as a low-level concern. Rebecca Ray, Executive Vice President, Human Capital, The Conference Board joined Cheddar's Opening Bell for more.
Investing in mRNA Technologies
David Maza, Managing Director and Head of Product at Direxion, joins Cheddar News to discuss the evolution of mRNA technologies, future applications of this tech including fighting Lyme disease and HIV, and what this all means for investors.
Predicting Major Market Trends for 2022
Thomas Hayes, Chairman at Great Hill Capital, joined Wake Up With Cheddar to break down what to look for on the economic front in the coming months amid an Omicron surge and planned interest rate hikes.
Load More